Cargando…
P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431264/ http://dx.doi.org/10.1097/01.HS9.0000848056.06353.f1 |
| _version_ | 1784780005766594560 |
|---|---|
| author | Von Roemeling, C. Iqbal, M. Doonan, B. Hoang-Minh, L. Klippel, K. Tun, H. Mitchell, D. |
| author_facet | Von Roemeling, C. Iqbal, M. Doonan, B. Hoang-Minh, L. Klippel, K. Tun, H. Mitchell, D. |
| author_sort | Von Roemeling, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431264 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312642022-08-31 P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA Von Roemeling, C. Iqbal, M. Doonan, B. Hoang-Minh, L. Klippel, K. Tun, H. Mitchell, D. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431264/ http://dx.doi.org/10.1097/01.HS9.0000848056.06353.f1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Von Roemeling, C. Iqbal, M. Doonan, B. Hoang-Minh, L. Klippel, K. Tun, H. Mitchell, D. P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA |
| title | P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA |
| title_full | P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA |
| title_fullStr | P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA |
| title_full_unstemmed | P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA |
| title_short | P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA |
| title_sort | p1298: the irak-4 inhibitor emavusertib (ca-4948) for the treatment of primary cns lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431264/ http://dx.doi.org/10.1097/01.HS9.0000848056.06353.f1 |
| work_keys_str_mv | AT vonroemelingc p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma AT iqbalm p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma AT doonanb p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma AT hoangminhl p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma AT klippelk p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma AT tunh p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma AT mitchelld p1298theirak4inhibitoremavusertibca4948forthetreatmentofprimarycnslymphoma |